Home
MBOT
MBOT News

Latest Microbot Medical Inc. (MBOT) News on February 22, 2025

Microbot Medical Closes $13 Million Registered Direct Offering

GlobeNewswire

11 days ago

Microbot Medical Closes $13 Million Registered Direct Offering

MT Newswires

12 days ago

Microbot Medical to Sell Common Stock Worth $13 Million

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

12 days ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

GlobeNewswire

18 days ago

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025

Insider Monkey

19 days ago

Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

GlobeNewswire

a month ago

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors

GlobeNewswire

a month ago

Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors

MT Newswires

a month ago

Microbot Medical Completes $8.6 Million Registered Direct Offering

Microbot Medical Closes $8.6 Million Registered Direct Offering

GlobeNewswire

a month ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical prices 3.79M shares at $2.27 in registered direct offering

TipRanks

a month ago

Microbot Medical prices 3.79M shares at $2.27 in registered direct offering

Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

a month ago

Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

GlobeNewswire

a month ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

2 months ago

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

GlobeNewswire

2 months ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Zacks

2 months ago

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Microbot Medical seeks FDA clearance for endovascular robotic system

Medical Device Network

2 months ago

Microbot Medical seeks FDA clearance for endovascular robotic system

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

GlobeNewswire

2 months ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

GlobeNewswire

2 months ago

Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial

Zacks

4 months ago

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial

Microbot eyes FDA application for surgical robot after completing pivotal trial

Medical Device Network

4 months ago

Microbot eyes FDA application for surgical robot after completing pivotal trial

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

GlobeNewswire

4 months ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

MT Newswires

5 months ago

Microbot Medical Says it Expects to Finish its ACCESS-PVI Robotic Surgical System Clinical Trial Ahead of Schedule

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

GlobeNewswire

5 months ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

GlobeNewswire

5 months ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical advances Liberty Robotic System telesurgery innovation

Medical Device Network

6 months ago

Microbot Medical advances Liberty Robotic System telesurgery innovation

Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY

Zacks

6 months ago

Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

GlobeNewswire

6 months ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical (MBOT) Gets Quality Certification for its System

Zacks

6 months ago

Microbot Medical (MBOT) Gets Quality Certification for its System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

GlobeNewswire

6 months ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics

Zacks

7 months ago

Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics

Microbot and Emory University to advance endovascular robotic system

Medical Device Network

7 months ago

Microbot and Emory University to advance endovascular robotic system

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

GlobeNewswire

7 months ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

GlobeNewswire

7 months ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical (MBOT) Progresses in Its Human Clinical Trial

Zacks

7 months ago

Microbot Medical (MBOT) Progresses in Its Human Clinical Trial

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

GlobeNewswire

7 months ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

MT Newswires

7 months ago

Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

GlobeNewswire

7 months ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial

Zacks

8 months ago

Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial

Microbot secures second site for Liberty endovascular robot trial

Medical Device Network

8 months ago

Microbot secures second site for Liberty endovascular robot trial

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY

Zacks

8 months ago

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY

MT Newswires

8 months ago

Microbot Medical Signs Clinical Trial Deal With Baptist Hospital of Miami

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

GlobeNewswire

8 months ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials

Medical Device Network

8 months ago

Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials

Microbot partners with Boston Hospital to trial Liberty surgical robot

Medical Device Network

8 months ago

Microbot partners with Boston Hospital to trial Liberty surgical robot

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

GlobeNewswire

8 months ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

GlobeNewswire

8 months ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

MT Newswires

8 months ago

Microbot Medical Files Common Stock Registration Statement

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

9 months ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot’s LIBERTY robotic system secures FDA approval for pivotal trial

Medical Device Network

9 months ago

Microbot’s LIBERTY robotic system secures FDA approval for pivotal trial

MT Newswires

9 months ago

Microbot Gets FDA Nod to Start Trial, to Raise $2.35 Million From Direct Offering Deal; Shares Soar

MT Newswires

9 months ago

Top Midday Gainers

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

9 months ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

GlobeNewswire

9 months ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

GlobeNewswire

10 months ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Microbot Medical Shares Status Following Recent Geopolitical Events

GlobeNewswire

10 months ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Microbot Medical (MBOT) Files IDE to Start Human Clinical Study

Zacks

a year ago

Microbot Medical (MBOT) Files IDE to Start Human Clinical Study

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

GlobeNewswire

a year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

GlobeNewswire

a year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Insider Monkey

a year ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Rhinebeck Bancorp, Inc. Reports Results for the Quarter and Year Ended December 31, 2023

ACCESSWIRE

a year ago

Rhinebeck Bancorp, Inc. Reports Results for the Quarter and Year Ended December 31, 2023

Chuck Royce Reduces Stake in Amtech Systems Inc

GuruFocus.com

a year ago

Chuck Royce Reduces Stake in Amtech Systems Inc

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

GlobeNewswire

a year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

StockStory

a year ago

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

GlobeNewswire

a year ago

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)

GlobeNewswire

a year ago

Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)

Microbot Medical (MBOT) Announces Positive GLP Study Results

Zacks

a year ago

Microbot Medical (MBOT) Announces Positive GLP Study Results

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

GlobeNewswire

a year ago

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%

Simply Wall St.

a year ago

Fossil Group (NASDAQ:FOSL) adds US$10m to market cap in the past 7 days, though investors from five years ago are still down 90%

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

GlobeNewswire

a year ago

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

GlobeNewswire

a year ago

UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

Business Wire

a year ago

Gold Resource Corporation Reports High Grade Drill Results at the Don David Gold Mine

Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

GlobeNewswire

a year ago

Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

3 Stocks at the Forefront of Medical Robotics

InvestorPlace

a year ago

3 Stocks at the Forefront of Medical Robotics

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Chairman Gubin’s comments pertaining to the Board’s Strategic Planning - “A successful roadmap for growing our Bank”

GlobeNewswire

a year ago

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Chairman Gubin’s comments pertaining to the Board’s Strategic Planning - “A successful roadmap for growing our Bank”

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

GlobeNewswire

a year ago

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

American Battery Technology Company Invited to Present at Expert Battery Metals and Recycling Industry Conferences

PR Newswire

a year ago

American Battery Technology Company Invited to Present at Expert Battery Metals and Recycling Industry Conferences

Investors in Profire Energy (NASDAQ:PFIE) have seen favorable returns of 90% over the past three years

Simply Wall St.

a year ago

Investors in Profire Energy (NASDAQ:PFIE) have seen favorable returns of 90% over the past three years

The Top 3 Most Promising Energy Penny Stocks to Buy

InvestorPlace

a year ago

The Top 3 Most Promising Energy Penny Stocks to Buy

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

The Wall Street Journal

a year ago

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

GuruFocus.com

a year ago

SuRo Capital Corp. Reports Notable Increase in Net Asset Value for Q3 2023

SuRo Capital Corp. Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

SuRo Capital Corp. Reports Third Quarter 2023 Financial Results

Why The ONE Group (STKS) Shares Are Sliding Today

StockStory

a year ago

Why The ONE Group (STKS) Shares Are Sliding Today

Tortoise Announces Preliminary Results of Tender Offers for its Closed-End Funds

ACCESSWIRE

a year ago

Tortoise Announces Preliminary Results of Tender Offers for its Closed-End Funds

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

GlobeNewswire

a year ago

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Li-Cycle to Host Third Quarter 2023 Earnings Conference Call/Webcast on Monday, November 13, 2023 at 4:15 p.m. (Eastern Time)

Business Wire

a year ago

Li-Cycle to Host Third Quarter 2023 Earnings Conference Call/Webcast on Monday, November 13, 2023 at 4:15 p.m. (Eastern Time)

Share on Social Networks: